secwatch.observer — SEC 8-K summary
======================================

Issuer:     LEMAITRE VASCULAR INC (LMAT)
CIK:        0001158895
Form:       8-K
Filed at:   2026-08-04T20:39:02+00:00
Accession:  0001193125-26-332982
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LeMaitre Q2 sales $70.4M (+10%), EPS $0.74 (+23%); Artegraft up 34%; guides FY $276.3M
--------------------------------------------------------------------------------

- Sales $70.4M, +10% YoY (+10% organic); EPS $0.74 (+23%).
- Gross margin 72.1% (+210 bps); operating income $20.4M (+26%).
- Artegraft sales +34%; approved in 56 countries, 21% of sales.
- FY guidance: sales mid $276.3M (+11% org), EPS mid $2.89 (+15% GAAP, +21% adj).
- Quarterly dividend $0.25/share payable Sept 3, 2026 to record Aug 20, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1158895/000119312526332982/0001193125-26-332982-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1158895/000119312526332982/d320964d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-332982

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer